COVID-19 Among Patients With Inflammatory Rheumatic Diseases

BACKGROUND: The course of novel coronavirus disease 2019 (COVID-19) has been of special concern in patients with inflammatory rheumatic diseases (IRDs) due to the immune dysregulation that may be associated with these diseases and the medications used for IRDs, that may affect innate immune response...

Descripción completa

Detalles Bibliográficos
Autores principales: Esatoglu, Sinem Nihal, Tascilar, Koray, Babaoğlu, Hakan, Bes, Cemal, Yurttas, Berna, Akar, Servet, Pehlivan, Ozlem, Akleylek, Cansu, Tecer, Duygu, Seyahi, Emire, Yuce-Inel, Tuba, Alpay-Kanitez, Nilufer, Bodakci, Erdal, Tekgoz, Emre, Colak, Seda, Bolek, Ertugrul Cagri, Koca, Suleyman Serdar, Kalyoncu, Umut, Icacan, Ozan Cemal, Ugurlu, Serdal, Oz, Hande Ece, Hamuryudan, Vedat, Hatemi, Gulen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086428/
https://www.ncbi.nlm.nih.gov/pubmed/33936073
http://dx.doi.org/10.3389/fimmu.2021.651715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086428/
https://www.ncbi.nlm.nih.gov/pubmed/33936073
http://dx.doi.org/10.3389/fimmu.2021.651715

Ejemplares similares